We are committed to fostering a positive and supportive work environment. Earlier this year, we had a fantastic time celebrating IBEC’s Workplace Wellbeing Day for the second year in a row. Our team enjoyed online coaching sessions, a refreshing lunchtime walk, and delicious healthy snacks and lunch. These activities weren’t just about promoting a happy and healthy workplace; they also encouraged interaction across departments, fostered connections, and strengthened our community. We’re already looking forward to the next one! #WorkplaceWellbeing #EmployeeWellbeing
About us
Xeolas Pharmaceuticals is an innovative specialty pharmaceutical company focused on the development and supply of patient-friendly medicines, tackling complex pharmaceutical development projects and realising solutions for patients with unmet medical needs. Xeolas is a business commercialising its products through licensees and distributors globally, with an EU approved R&D & manufacturing facility in Ireland. We proudly bring innovation to the space between big pharma and generics, welcoming the opportunity to establish new partnerships.
- Website
-
www.xeolas.com
External link for Xeolas Pharmaceuticals
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Dublin
- Type
- Privately Held
Locations
-
Primary
Dublin, IE
Employees at Xeolas Pharmaceuticals
-
Jennifer O'Donovan
Laboratory Manager at Xeolas Pharmaceuticals
-
Maurice Clancy
R&D Director / Production Director at Xeolas Pharmaceuticals
-
Aoife Newman
EHS Officer at Xeolas Pharmaceutical
-
Eugene Quinn
Pharmaceutical Formulation | Process Development | Validation | Technology Transfer | Scale-up | Intellectual Property
Updates
-
We’re thrilled to announce that our team will be attending CPHI Milan this October. Contact us to arrange a meeting with Andrew Broderick (Commercial Director), Dennis McDaid (Technical Director) or Dolores Lynch (Operations Director), and discover Xeolas' cutting-edge solutions addressing unmet patient needs. We’re looking forward to making connections, meeting industry professionals, and gaining fresh insights. Let’s connect and drive innovation forward! #CPHIMilan2024
-
Are you curious about life at Xeolas? Here at Xeolas, we are on a mission to create medicines that put patients with medical needs first. We are currently a team of 75 dedicated individuals driven by innovation, ambition, quality and teamwork, supporting each other every step of the way. Together, we work to make a positive impact in the healthcare field. Check out this testimonial from one of our team members, we invite you to visit our career page and discover what our team has to say: https://lnkd.in/ehrYjE-J #Xeolas #EmployeeTestimonial
-
At Xeolas, we are experts in researching, developing, and manufacturing stable and effective complex formulation solutions. Here’s why they are a game-changer: - Versatile and patient-friendly option for medication delivery, especially for those with swallowing difficulties. - Enhanced stability: Perfect for challenging drugs and biopharmaceutics. - Flexible dosing: Allows for individualised treatment plans, optimising therapeutic efficacy. Our patented technologies ensure innovative and reliable solutions for better patient outcomes. #Xeolas #Pharmaceuticals #PatientCare #ComplexFormulations #DrugDevelopment
-
Take a behind-the-scenes look at our manufacturing facility. Here, our dedicated team works together to develop and produce high-quality products destined to be distributed globally, ultimately making a difference in patient’s lives. From formulation to clinical testing to regulatory submission, we're committed to efficiency and excellence every step of the way. #Xeolas #Manufacturing #BehindTheScenes #Quality #PatientFriendlyMedicines
-
Today, we would like to introduce a pivotal concept that drives Xeolas: Unmet Medical Needs (UMN). Discover why this concept is incredibly important to us. UMN is a widely used term with no universal definition in healthcare. It generally refers to gaps present in available therapies or non-existent treatments for managing certain diseases and conditions. For us, it is crucial to understand and address UMN. We prioritise identifying those gaps in the current healthcare landscape. We strive to develop safe, effective and tailored treatment options that can better meet the unique requirements of patients. It can improve health outcomes, enhance quality of life and provide much-needed support for patients and their caregivers. Keen to learn more about how we're making a difference in addressing Unmet Medical Needs (UMN) in healthcare? Dive deeper into our website to explore our approach and ongoing initiatives. Click here to discover more: https://lnkd.in/gXmn9M7J #Xeolas #UMN #Healthcare #PatientFriendlyMedicines
-
In this post, we proudly want to give you a sneak peek into what makes Xeolas special. At our core, you will discover a blend of innovation, quality, ambition and teamwork. These values aren’t just words, they are the driving force behind everything we do. #Xeolas #Values #Culture #Innovation #Ambition #Quality #Teamwork
-
We are delighted to connect with you on Linkedin. We are Xeolas, an innovative pharmaceutical company based in Dublin. Follow us and stay tuned for the latest updates and opportunities to engage! #Xeolas #Welcome #Pharmaceutical #Followus